Physician profile
Don Heacock
NPI 1447292008
$3,519.28
in general payments reported to CMS, 2019-2025
24 companies · $727 in 2025
The $727 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $194 · 2021: $540 · 2022: $539 · 2023: $689 · 2024: $438 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $772.49 | 2019-2025 | Tremfya, Simponi, Remicade |
| Abbvie INC. | $391.36 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $237.48 | 2019-2024 | |
| Novo Nordisk INC | $237.39 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $225.00 | 2021-2024 | Dificid |
| Ironwood Pharmaceuticals, INC | $221.56 | 2019-2023 | Linzess |
| Regeneron Healthcare Solutions, INC. | $178.60 | 2022-2024 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.12 | 2019-2023 | Trulance |
| Genzyme Corporation | $155.17 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $131.19 | 2022 | |
| Csl Behring | $123.56 | 2021-2023 | Kcentra |
| Takeda Pharmaceuticals U.S.A., INC. | $98.37 | 2019-2024 | Eohilia |
| Pfizer INC. | $96.88 | 2024-2025 | |
| Ardelyx, INC. | $92.10 | 2023-2025 | Ibsrela |
| Celgene Corporation | $85.56 | 2021-2023 | Zeposia |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $75.85 | 2019-2020 | |
| Qol Medical, LLC | $64.58 | 2024 | Sucraid |
| Gilead Sciences, INC. | $35.75 | 2019-2020 | |
| Redhill Biopharma INC. | $32.83 | 2021-2023 | Aemcolo, Talicia, Movantik |
| Medtronic, INC. | $25.51 | 2025 | Emprint |
| Nestle Healthcare Nutrition INC. | $17.92 | 2021 | |
| Mauna Kea Technologies, INC. | $17.31 | 2025 | |
| Evoke Pharma, INC. | $16.52 | 2023 | Gimoti |
| Phathom Pharmaceuticals, INC. | $8.18 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Heacock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.